Confirmatory phase IIb study evaluating topical clonidine gel for painful diabetic neuropathy

Trial Profile

Confirmatory phase IIb study evaluating topical clonidine gel for painful diabetic neuropathy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2013

At a glance

  • Drugs Clonidine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2013 Status changed from planning to discontinued, according to a BioDelivery Sciences International media release announcing that the company is proceeding to phase III trials instead of this confirmatory phase IIb trial.
    • 03 Apr 2013 New trial record
    • 26 Mar 2013 Data may be potentially available before the end of 2014, according to a BioDelivery Sciences International media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top